Boston Medical Center/Brighton

Boston Medical Center/Brighton operates as a hospital program at 736 Cambridge Street in Brighton, Massachusetts, delivering a full continuum of addiction treatment services under the broader BMC Health System. The facility’s Addiction Medicine department anchors its clinical programming, situating withdrawal management and medically supervised care within an established hospital infrastructure rather than a standalone clinic setting. For individuals and families researching medical detox options in the Suffolk County area, the hospital-program designation signals a level of clinical oversight that distinguishes it from community-based outpatient centers.

The facility’s confirmed levels of care span medical detox, residential treatment, a standard outpatient program, and an intensive outpatient program (IOP). Medical detox sits at the top of that continuum, providing the structured withdrawal management that patients with physical dependence typically require before stepping down to lower levels of care. The certified Opioid Treatment Program (OTP) status further supports medically supervised opioid treatment, including medication assisted treatment documented on the facility’s own website.

Boston Medical Center/Brighton also addresses co-occurring disorders and trauma or PTSD alongside addiction treatment, recognizing that dual diagnosis presentations are common among people seeking detox and residential care. The Addiction Medicine and Behavioral Health departments both appear among the facility’s listed services, reflecting a clinical structure capable of managing complex cases that extend beyond substance use alone.

The center serves a notably broad range of populations, including veterans, pregnant women, seniors and older adults, men, women, individuals with HIV/AIDS, those who are deaf or hard of hearing, and court-ordered patients. Payment options include Medicaid, Medicare, TRICARE, private insurance, and self-pay, removing common financial barriers for patients across different coverage situations. For individuals who need medically supervised detox within a hospital-level program that accepts a wide range of insurance types and serves diverse patient populations, Boston Medical Center/Brighton offers a clinically grounded option in Brighton, MA.

Boston Medical Center/Brighton provides medical detox as the entry point of its addiction treatment continuum, housed within a hospital program at 736 Cambridge Street in Brighton, MA. The hospital-program designation means that detox and withdrawal management occur within a clinical environment that includes access to the broader resources of the BMC Health System — a meaningful distinction for patients whose withdrawal presentations require close medical attention.

Following stabilization through medical detox, patients can transition into residential treatment, an outpatient program, or an intensive outpatient program (IOP) within the same system. This continuity reduces the logistical and clinical gaps that often occur when patients must transfer between unaffiliated providers after completing detox.

Boston Medical Center/Brighton holds certification as an Opioid Treatment Program (OTP), which authorizes the facility to deliver medication assisted treatment (MAT) for opioid use disorder. The center's own Addiction Medicine department is documented as offering outpatient addiction treatment that includes MAT, providing a pharmacological component to care that OTP certification specifically enables.

For patients and families evaluating opioid detox programs, OTP certification is a federally regulated designation — not a self-reported marketing claim — indicating that the program meets specific standards for opioid treatment delivery. This certification, combined with the facility's hospital-program status, positions Boston Medical Center/Brighton among the more clinically structured opioid treatment options in Brighton, Massachusetts.

Many individuals entering medical detox or residential treatment present with co-occurring mental health conditions alongside substance use disorders. Boston Medical Center/Brighton confirms treatment of co-occurring disorders and dual diagnosis, as well as trauma and PTSD, within its clinical scope. The presence of both Addiction Medicine and Behavioral Health departments within the facility supports integrated care for patients whose needs span both domains.

Addressing a dual diagnosis from the outset of detox — rather than deferring mental health treatment until after withdrawal management — is clinically significant. Untreated psychiatric symptoms can complicate withdrawal, increase dropout risk, and undermine longer-term outcomes. The facility's confirmed capacity to treat these conditions concurrently reflects a clinical orientation suited to complex presentations.

Boston Medical Center/Brighton explicitly serves veterans, pregnant women, seniors and older adults, men, women, individuals with HIV/AIDS, those who are deaf or hard of hearing, and court-ordered patients. This breadth of population coverage is atypical among detox programs, which often serve more narrowly defined demographics. Veterans and court-ordered patients in particular benefit from a provider equipped to navigate their respective clinical and administrative requirements.

On the financial side, the facility accepts Medicaid, Medicare, TRICARE, private insurance, and self-pay. TRICARE acceptance directly supports access for active-duty military, veterans, and their dependents. The combination of Medicaid and Medicare acceptance makes the program reachable for lower-income individuals and older adults who might otherwise be screened out by facilities with more limited payer participation.